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Abstract The SR Ca-ATPase in skeletal muscle SR vesicles 
isolated from young adult (5 months) and aged (28 months) rats 
was analyzed for nitrotyrosine. Only the SERCA2a isoform con- 
tained significant amounts with approximately one and four nitro- 
tyrosine residues per young and old Ca-ATPase, respectively. 
The in vitro exposure of SR vesicles of young rats to peroxynitrite 
yielded selective nitration of the SERCA2a Ca-ATPase even in 
the presence of excess SERCAla. No nitration was observed 
during the exposure of SR vesicles to nitric oxide in the presence 
of 02. These data suggest he in vivo presence of peroxynitrite 
in skeletal muscle. The greater nitrotyrosine content of 
SERCA2a from aged tissue implies an age-associated increase 
in susceptibility to oxidation by this species. 
Key words: Peroxynitrite; Nitric oxide; Nitrotyrosine; Reactive 
oxygen species; Aging; SR Ca-ATPase 
I. Introduction 
The post-translational modification of proteins by reactive 
oxygen species has been recognized as an important feature of 
biological oxidative stress [1]. Significant levels of such modi- 
fied proteins can accumulate in aged biological tissue [2-5], 
eventually paralleled by altered enzyme activities dependent 
upon the nature of the covalent protein modification. The 
amount of modified protein present may be used as a biological 
marker to assess potential levels of oxidative stress as well as 
the capacity of an organism to cope with such stress. Recently, 
peroxynitrite (ONOO-) has been identified as a potentially 
harmful reactive oxygen species due to the high reactivity and 
selectivity in its reactions with biomolecules such as lipids and 
proteins [6-8]. Peroxynitrite forms under conditions of simulta- 
neous generation of superoxide and nitric oxide (reaction 1; 
kl = 4.3-6.7 x 109 M - I 's  -~ [9,10]). 
NO" + O'y --~ ONOO- (1) 
Its reaction with tyrosine leads to oxidation, hydroxylation and 
*Corresponding author. Fax: (1) (913) 842-5612. 
Abbreviations: DEA/NO, diethylamine/nitric oxide complex sodium 
salt; DTT, dithiothreitol; MOPS, 3-(N-morpholino)propanesulfonic 
acid; SDS-PAGE, sodium dodecylsulfate-polyacrylamide gel electro- 
phoresis; SR, sarcoplasmic reticulum. 
to ortho-nitrotyrosine [11,12]. The latter has been discussed as 
a biological marker for the assessment of the exposure of tissue 
to oxidative stress, and, in particular, nitric oxide-derived reac- 
tive oxygen species. Significant amounts of nitrotyrosine have, 
for example, been detected in human atherosclerotic ssue [13]. 
We have focused on the role of peroxynitrite in the modifica- 
tion of biological tissues during biological aging. The observa- 
tion that skeletal muscle of aged individuals hows increased 
relaxation times has been correlated with a potential age-re- 
lated dysfunction of the sarcoplasmic reticulum (SR) Ca-ATP- 
ase [14]. Pending a detailed analytical characterization f possi- 
ble age-related covalent modifications ofthis protein, it appears 
reasonable that reactive oxygen species could be responsible for 
such modifications since they are actively involved in the mod- 
ulation of skeletal muscle function [15,16]. For example, super- 
oxide dismutase-sensitive reactive oxygen species have been 
found to account for 85% of a 6-fold increase of cytochrome 
c reducing equivalents in actively contracting muscle as com- 
pared to resting muscle [16], suggesting a specific role for super- 
oxide. Moreover, it has been demonstrated that constitutive 
nitric oxide synthase is highly expressed in skeletal muscle [17] 
and that nitric oxide (NO) may modulate skeletal muscle con- 
traction [16]. 
Due to the simultaneous generation of NO and superoxide 
we expect hat skeletal muscle will be periodically exposed to 
peroxynitrite. The present paper will demonstrate hat during 
biological aging significant amounts of nitrotyrosine accumu- 
late on the skeletal muscle SR Ca-ATPase and that this modi- 
fication is selective to the SERCA2a slow-twitch isoform of the 
Ca-ATPase. In vitro oxidation experiments with skeletal SR 
vesicles containing both fast- and slow-twitch muscle will show 
that peroxynitrite is able to selectively nitrate the SERCA2a 
(slow-twitch) isoform even in the presence of excess SERCAla 
(fast-twitch) isoform, and thus we suggest hat peroxynitrite 
may be responsible for the in vivo accumulation of nitroty- 
rosine on SERCA2a. 
2. Materials and methods 
2.1. Chemicals 
The following chemicals were purchased from the respective sources: 
monoclonal antibodies to SERCA1 and SERCA2a (Affinity Biorea- 
gents); anti-nitrotyrosine monoclonal antibody (Upstate Biotechnol- 
ogy); goat anti-mouse IgG(H+L) HRP conjugate (Pierce); 3-(N-mor- 
pholino)propanesulfonic a id (MOPS), soybean trypsin inhibitor, 
TPCK-treated trypsin, 4-chloro-l-naphthol, 3-nitrotyrosine (Sigma). 
All other chemicals were analytical grade products. Nitric oxide was 
prepared in situ by the release of NO from diethylamine/nitric oxide 
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complex sodium salt (DEA/NO; Research Biochemicals International), 
essentially as described by Maragos et al. [18]. Peroxynitrite was synthe- 
sized by ozonization of ice-cooled aqueous odium azide at pH 12, 
essentially as described [19] (precautions for the procedure are de- 
scribed in ref. [19]). The actual peroxynitrite concentrations were deter- 
mined before each experiment at "~max = 302 nm taking es02 = 1,670 
M -I "cm -1 [20]. 
2.2. Animals and &olation of sarcoplasmic reticulum 
Native SR vesicles were prepared from rat hindlimb muscles accord- 
ing to Ferrington et al. [21]. For each preparation, SR membranes were 
isolated from equal numbers (3 animals per preparation) of young (5 
months) and old (28 months) adult male Fisher strain 344 rats obtained 
from the National Institute of Aging maintained rat colony (Harlan 
Sprague Dawley, Inc., Indianapolis). Prior to sacrificing, the rats were 
generally allowed to recover for two weeks after arrival. SR vesicles 
were suspended in a medium consisting of 0.3 M sucrose and 20 mM 
MOPS (pH 7.0) and stored at -70°C. Protein concentration was deter- 
mined by the Lowry method [22] using bovine serum albumin as a 
standard. 
2.3. Polyacrylamide gel electrophoresis 
SDS-PAGE was performed using a 5% Laemmli gel with a 3% stack- 
ing gel [23], resolving both the fast-twitch and slow-twitch isoforms of 
Ca-ATPase, SERCAla and 2a, respectively. Peptide fragments A, A~, 
A2, and B, obtained by limited tryptic digest, were separated on a 10% 
tricine gel [24]. Gels were either stained for protein with Coomassie blue 
or electroblotted. The relative amount of Ca-ATPase in the SR prepa- 
rations was determined from computerized ensitometric measure- 
ments of the protein band migrating with an apparent molecular weight 
of 110,000 Da. 
2.4. Western blotting of Ca-ATPase isoforms and nitrotyrosine 
SR proteins were separated by 5% Laemmli SDS-PAGE or a 10% 
tricine gel, respectively, and then transferred tonitrocellulose paper (0.4 
pm pore size) electrophoretically for 2.5 h at 90 V using 25 mM Tris, 
195 mM glycine, and 20% methanol as the transfer buffer. Western 
blotting was done as previously described [25]. The primary antibodies 
for SERCAla, SERCA2a and nitrotyrosine were diluted 1:2000, 
1 : 250, and 1 : 1000, respectively. The secondary goat anti-mouse IgG- 
HRP- linked antibody was diluted 1:10,000. Color development of the 
blots was accomplished using 4-chloro-1-naphthol (3 mg/ml methanol) 
and 20 pl of 30% H202 in 20 ml of TBS. Quantitation of the signals was 
accomplished by computerized densitometry (area × intensity). 
Amounts of 50-200 ¢tg of SR protein provided a linear esponse for the 
quantitation of the SERCA2a antibody. 
2.5. Preparation of protein for amino acid analysis 
The SERCA2a was purified by preparative SDS gel electrophoresis 
(5% separating els, 165 x 165 x 0.8 mm according to ref. [26]). After 
electrophoresis the gels were stained for 30 min with freshly prepared 
0.1% Coomassie Blue R-250 in 10% methanol and 0.5% acetic acid and 
subsequently destained with 10% methanol (4 x 5 min). The band cor- 
responding to SERCA2a (as identified by labeling with SERCA2a 
antibody; see below) was cut out and washed 10 min in the electroelu- 
tion buffer (20 mM Tris, pH 8.3, 150 mM glycine, 0.1 mM DTT, 0.025% 
SDS). The samples were frozen overnight before lution in a Little Blue 
Tank electroelutor (ISCO). Before collection of the samples, the current 
was reversed for 30 s to desorb the proteins from the membranes. Salts 
and SDS were removed as described [26]. 
2.6. Amino acid analysis 
Amino acid analysis was done after hydrolysis of the protein in 
(i) 6 N HC1, and (ii) 4 N methanesulfonic acid, respectively (20 h, 110°C). 
Services were provided by Commonwealth Biotechnologies, Inc. 
(Richmond, VA). 
2. 7. Limited tryptic digestion 
SR vesicles (4 mg/ml SR protein) were digested with trypsin at a ratio 
of trypsin/SR protein of 1:100 up to 35 min at 25°C in 80 mM KCI, 
and 20 mM MOPS, pH 7.0 [27]. The reaction was stopped by addition 
of soybean trypsin inhibitor (type l-S, Sigma) at an inhibitor/trypsin 
ratio of 2:1. 
2.8. HPLC of nitrotyrosine 
For the analysis of nitrotyrosine, an aliquot of SR protein was hydro- 
lyzed for 20 h at 110°C in a gas phase hydrolyzer before HPLC analysis 
was performed according to the method escribed in reference [28]. In 
brief, samples were separated on an Inertsil ODS-3 column (GL Sci- 
ences, Inc.), eluted isocratically at 0.7 ml/min with a mixture of 0.03 M 
sodium acetate and 0.03 M sodium citrate, pH 3.6. Nitrotyrosine eluted 
with tR -= 54.0 + 0.3 rain, as monitored by parallel UV-detection at 275 
and 350 nm. We observed a linear response and satisfactory signal to 
noise level of nitrotyrosine standards at concentrations of [NO2- 
Tyr] >- 0.1 ,uM. Furthermore, in control experiments hydrolysates of 
SR protein were spiked with authentic ortho-nitrotyrosine. 
2.9. Statistics 
For the in vivo determinations of nitrotyrosine 5 groups of animals, 
each of them containing 3 rats, were sacrificed for young and old rats, 
respectively. The values in the Figures and the Table are expressed as 
mean + S.E.M for n experiments. Groups were compared by t-test. 
Significance was set at P < 0.01. 
3. Results 
3.1. In vivo formation of nitrotyrosine during aging 
Fig. 1A demonstrates that SR vesicles, obtained from aged 
(28 months old) rats contain nitrotyrosine ssentially only on 
the SERCA2a isoform of the SR Ca-ATPase and not on the 
SERCA 1 a isoform, as indicated by the immunoreactivity of the 
corresponding protein bands with both the nitrotyrosine and 
SERCA2a antibodies. Similar results were obtained for 
+ anti-n itrotyrosine + anti-Serca 2a 
Serca la -  
Serca 2a- 
A.  
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Fig. 1. (A) Immunodetection f nitrotyrosine and SERCA2a in SR 
vesicles from aged rats (28 months old). Lanes 1 and 6 (prepared in 
winter), lanes 2 and 7 (prepared in spring), lanes 3 and 8 (prepared in 
summer). The amount of applied protein was 100 ¢tg per lane. Lanes 
4 and 5: molecular weight standards (Bio-Rad): 205 kDa, 121 kDa, 86 
kDa and 50.7 kDa. (B) Immunodetection f nitrotyrosine in the major 
tryptic fragments of SERCA2a. Lane 1: Molecular weight standard 
(Bio-Rad): 205, 121, 86, 50.7, 33.6, 27.8, 19.4 and 7.4 kDa. Lane 2: 
trypsin (5 ,ug) + trypsin inhibitor (10/.tg) (control experiment). Lanes 
3-10: Aliquots of SR vesicles after different imes of digestion: 0 min 
(lane 3), 5 min (lane 4), 10 min (lane 5), 15 min (lane 6), 20 rain (lane 
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Fig. 2. Ratio of nitrotyrosine/Serca2a in SR vesicles of young (5 months 
old; panels I-V) and old (28 months old; panel VI) rats, determined by 
immunoreactivity. Young rats: control, (I); exposed to NO/O2, (II); 
exposed to 56 pM peroxynitrite, (III); exposed to 200/.tM peroxynitrite, 
(IV); exposed to 200 mM peroxynitrite in the presence of 2 pM SOD, 
(V). Panels are significantly different at the following levels: I and II, 
P < 0.5; I and III, P < 0.01; I and IV, P < 0.001; IV and VI, P < 0.05. 
SERCA2a of young (5 months old) rats (blot not shown). The 
densitometric analysis of the Western blots shown in Table 1 
(second column) reveals that SR vesicles from aged rats display 
a nitrotyrosine/SERCA2a ratio which is 4-fold higher in old as 
compared to young rats. Thus, SERCA2a Ca-ATPase of aged 
rats is characterized by elevated levels of nitrotyrosine. 
Our SR preparations contain approximately 40% Ca-ATP- 
ase relative to total SR protein, with approximately 10% of the 
Ca-ATPase content being the SERCA2a isoform, as estimated 
from the area of the Ca-ATPase band reacting with the 
SERCA2a antibody (Ferrington et al., unpublished ata). Im- 
portantly, SR preparations were nearly identical; aged rats had 
slightly less (4%) total Ca-ATPase protein compared to young 
rats (Ferrington et al., unpublished ata). With a molecular 
weight of SERCA2a of 109,477 Da [29] we calculate that 1 mg 
of SR protein contains 0.37 nmol of SERCA2a. When SR 
vesicles were subjected to gas phase hydrolysis followed by 
HPLC analysis, a content of 0.52 + 12 nmol nitrotyrosine/mg 
SR protein was obtained for young rats (see Table 1), corre- 
sponding to a molar ratio for nitrotyrosine/SERCA2a of
1.4 + 0.33. This is close to the ratio of 1.11 determined by 
Western blot analysis (see Table 1). For aged rats we obtained 
an absolute content of 1.43 + 0.16 nmol nitrotyrosine per 1 mg 
SR protein, corresponding to a molar ratio for nitrotyrosine/ 
SERCA2a of 3.9 + 0.4. This value matches the ratio obtained 
by the densitometry of the Western blots. Amino acid analysis 
of purified SERCA2a reveals a loss of two tyrosine residues 
from SERCA2a isolated from old rats (see Table 1). The num- 
ber of 18 + 0.7 tyrosine residues for young rats corresponds to 
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the published sequence of SERCA2a [29]. We suspect hat the 
amount of 1.4 nitrotyrosine residues, measured by HPLC for 
SERCA2a from young rats, may partially be accounted for by 
the error limit of +0.7 of the amino acid analysis. 
In summary, three independent analysis reveal that skeletal 
muscle SR vesicles, isolated from aged rats, are characterized 
by a 2- to 4-fold higher relative amount of nitrotyrosine as 
compared to young rats, corresponding to approximately 24  
nitrotyrosine residues per SERCA2a monomer. 
3.2. The localization of nitrotyrosine 
The limited proteolysis of SR protein (containing both 
SERCAla and SERCA2a) yields subfragments A, A1, A2, and 
B [27]. Fig. 1B displays the results of immunoblotting of these 
respective fragments from aged rats with the nitrotyrosine anti- 
body. It is apparent that the nitrotyrosine r sidues are located 
predominantly on the B-fragment which comprises residues 
ThrS°6Glu997 and contains 9 out of the total 18 tyrosine resi- 
dues [29]. We note a slight immunoreactivity of the A i-fragment 
whereas no immunoreactivity is observed for the A-fragment 
(comprising AI+A2). At present we cannot conclusively explain 
this observation except assuming that a large excess of non- 
nitrotyrosine-containing A-fragment from SERCAla may 
mask small amounts of nitrotyrosine-containing A-fragment of 
SERCA2a on the blot. There is significant difference in charge 
of the smaller Al-fragments from SERCAla (-3) and 
SERCA2a (+3) which may be sufficient for partly resolution 
on the blot, eventually permitting immunoreactivity of the 
SERCA2a A~-fragment with the nitrotyrosine antibody. 
3.3. The reaction of skeletal muscle SR vesicles with 
peroxynitrite 
We reacted SR vesicles (10 mg SR protein/ml) isolated from 
young rats, with (i) 56 pM peroxynitrite, (ii) 200 pM peroxyni- 
trite, and (iii) 200pM peroxynitrite in the presence of 2/.tM Cu, 
Zn superoxide dismutase (10 mM potassium phosphate, treated 
with Chelex-100, pH 7.3, 100 mM NaC1, 25°C). The addition 
of minute amounts of alkaline peroxynitrite stock solutions 
shifted the pH of the reaction mixtures by less than 0.2 pH 
units. Fig. 2 displays the respective yields of nitrotyrosine, x- 
pressed as ratio of nitrotyrosine/SERCA2a, obtained by den- 
sitometric analysis of Western blots, essentially as described for 
Fig. 1. Panel I displays the results of a control experiment in 
which a peroxynitrite solution was allowed to decompose [30] 
before it was combined with SR vesicles ('reverse-order-of- 
addition experiment' [30]). The amount of detected nitroty- 
rosine was identical to that measured for young SR vesicles in 
the absence of peroxynitrite, indicating that peroxynitrate de- 
composition products did not contribute to the formation of 
Table 1 
Nitrotyrosine content in rat skeletal SR preparations 
Age Nitrotyrosine/ Nitrotyrosine, Tyrosine, 
Serca2a nmol/mg SR res./mol 
ration a protein b Serca 2a ~ 
5 months 1.11 + 0.13 0.52 + 0.12 18 + 0.7 
28 months 4.20 + 0.41 1.43 + 0.16 16 + 0.9 
"Data are obtained by densitometry ofWestern blot. 
bData obtained by reversed-phase HPLC. 
c Data obtained by amino acid analysis. Samples of 5 and 28 month old 
rats are significantly different at the level of P < 0.01. 
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nitrotyrosine. The exposure of 10 mg SR protein/ml to 56/IM 
peroxynitrite (panel III) shows little elevation of nitrotyrosine 
levels over that of the control experiment. However, 200/.tM 
peroxynitrite (panel IV) form significant yields of nitrotyrosine 
which can be slightly enhanced by the addition of SOD (panel 
V). It has been shown that SOD can catalyze the nitration of 
tyrosine [11]. However, the small effect of SOD on the nitration 
of SERCA2a may be rationalized by the large size of the mem- 
brane protein potentially hampering interaction of a peroxyni- 
trite-SOD complex with tyrosine residues of SERCA2a. 
There was no significant formation of nitrotyrosine when 
air-saturated mixtures containing 10 mg SR protein/ml were 
exposed over 20 min to 200/.tM DEAfNO at 25°C (panel II). 
DEA/NO yields 1.5 equivalents of NO per DEA/NO [18]. 
4. Discussion 
Significant levels of nitrotyrosine accumulate on the 
SERCA2a isoform of Ca-ATPase during biological aging. 
However, also SERCA2a isolated from young rats carries an 
average of 1.4 nitrotyrosine r sidues per protein monomer. The 
exposure of SR vesicles to peroxynitrite r sults in the selective 
nitration of tyrosine residues of the SERCA2a isoform even in 
the presence of an excess content of SERCA1 a. These observa- 
tions suggest that the isolation of selectively nitrated SERCA2a 
cannot be rationalized by a potentially fast protein turnover of 
nitrated SERCAla (escaping detection) but may represent 
structural differences of the two isoforms rendering the 
SERCA2a tyrosine residues more susceptible to the reaction 
with peroxynitrite (we note that SERCA2a carries only 18 
tyrosine residues [29] as compared to 23 tyrosine residues of 
SERCAla [31]). These results are corroborated by recent more 
mechanistical studies in which we had shown that the in vitro 
reaction of peroxynitrite with rabbit SERCAla in SR vesicles 
did not result in the nitration of tyrosine residues but rather the 
oxidation of protein thiols [25]. 
The fact that nitrotyrosine was identified in SERCA2a of 
both young and old rats suggests that significant levels of per- 
oxynitrite are formed under physiological conditions of muscle 
contraction and relaxation through simultaneous generation of 
modulating levels of superoxide and NO [16]. Higher yields of 
nitrated SERCA2a in aged tissue may be explained by a gener- 
ally less effective antioxidant defense system of aged organisms 
[32]. Thus, nitrated SERCA2a may serve as a biological marker 
for both the exposure of skeletal muscle to peroxynitrite as well 
as for its capability to buffer (scavenge) reactive oxygen species 
such as peroxynitrite. 
Aerobic (air-saturated) mixtures containing NO at total con- 
centrations imilar to the employed peroxynitrite concentra- 
tions did not promote nitrotyrosine formation. This may be 
explained by the competitive reaction of other amino acid res- 
idues with NO-derived reactive intermediates different from 
peroxynitrite and/or before peroxynitrite formation may occur. 
Wink et al. have investigated NO/Oz systems, and their kinetic 
measurements postulate a yet unidentified intermediate which 
reacts approximately 150 times faster with sulfhydryl groups 
than with a standard peptide alanyltyrosine [33]. A rate con- 
stant of k2 > 3.4 x 103 M -1. s -t has been estimated for the for- 
ward reaction of equilibrium 2 [34], the primary equilibrium 
encountered by NO at [02] >> [NO]steady-state (kNo + NO > 2 X 103 
M -I" s -1 [34]). 
NO + 0 2 ~,~ONOO" (2) 
The resulting peroxylradical, ONOO °, is expected to oxidize 
thiols but most probably via an overall two-electron oxidation 
(reaction 3) [35]. The product °NO2 reacts efficiently with thiols 
[36] with an estimated overall rate constant in aqueous olution 
ofk 4 > 5 x 108 M-Is • -1 [37], where reaction 4proceeds via inter- 
mediary adducts uch CysS°(NO2)H and S-nitroso thiols [36]. 
(CysS- = cysteine thiolate.) 
ONOO ° + RSH --+ °NO 2 + RSOH (3) 
°NO 2 + CysS- ~ ~ NO~ + CysS" (4) 
Thus, protein thiols may efficiently compete for NO-derived 
reactive species in the NOLO2 system before any nitration can 
occur, and experiments are currently underway to test this 
hypothesis. Future experiments will now focus on the physio- 
logical significance of the nitration of the SERCA2a isoform 
of skeletal muscle Ca-ATPase by peroxynitrite. 
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